{"acute generalised exanthematous pustulosis": 2.01, "acute graft versus host disease": 2.35, "acute lymphocytic leukaemia": 7.85, "acute lymphocytic leukaemia recurrent": 5.57, "acute myeloid leukaemia": 4.47, "acute pulmonary oedema": 2.73, "acute respiratory distress syndrome": 2.06, "adrenal insufficiency": 3.19, "allergy test negative": 37.23, "anaemia": 2.21, "anaphylactic shock": 2.21, "aspergillus infection": 10.17, "atelectasis": 3.14, "bacteraemia": 4.78, "bacterial infection": 2.88, "bacterial sepsis": 5.12, "basal cell carcinoma": 2.91, "blood disorder": 2.21, "blood lactate dehydrogenase increased": 2.79, "bone lesion": 11.77, "bone marrow failure": 2.15, "brain abscess": 8.32, "brain oedema": 3.06, "bronchopulmonary aspergillosis": 13.36, "candida infection": 4.09, "cardiac failure": 2.34, "cardiomegaly": 2.26, "cardiotoxicity": 4.54, "cell-mediated cytotoxicity": 210.58, "cellulitis": 2.32, "central nervous system lesion": 3.62, "chronic graft versus host disease": 3.02, "clostridium difficile colitis": 4.38, "constipation": 2.15, "corneal oedema": 4.16, "covid-19 pneumonia": 2.81, "cryptococcosis": 23.84, "cushing's syndrome": 4.09, "cytokine release syndrome": 2.57, "cytomegalovirus chorioretinitis": 24.2, "cytomegalovirus infection": 4.16, "cytomegalovirus infection reactivation": 7.18, "cytopenia": 12.95, "deep vein thrombosis": 2.08, "diffuse large b-cell lymphoma": 13.81, "diffuse large b-cell lymphoma recurrent": 29.72, "diffuse large b-cell lymphoma refractory": 51.72, "disease progression": 7.25, "disease recurrence": 2.33, "disseminated cryptococcosis": 35.35, "disseminated intravascular coagulation": 2.4, "drug ineffective for unapproved indication": 3.23, "drug resistance": 2.68, "endophthalmitis": 2.49, "enterococcal infection": 7.26, "enterocolitis": 2.0, "epstein-barr virus infection": 2.3, "escherichia infection": 2.67, "escherichia sepsis": 12.85, "febrile bone marrow aplasia": 5.39, "febrile neutropenia": 11.43, "foetal exposure during pregcy": 3.45, "foetal growth restriction": 3.75, "follicular lymphoma": 14.83, "full blood count decreased": 7.37, "gastrointestinal necrosis": 3.92, "gastrointestinal perforation": 2.82, "haematotoxicity": 6.53, "haemodynamic instability": 2.32, "haemophagocytic lymphohistiocytosis": 6.24, "haemorrhoidal haemorrhage": 3.17, "hepatitis b": 2.93, "hepatitis b reactivation": 15.25, "hepatotoxicity": 2.24, "herpes simplex encephalitis": 50.57, "hiccups": 3.3, "hydrocephalus": 3.57, "hypercalcaemia": 3.03, "hyperglycaemia": 2.03, "hypertransaminasaemia": 2.05, "hypertriglyceridaemia": 3.43, "hypervolaemia": 3.18, "hypocalcaemia": 2.93, "hypogammaglobulinaemia": 10.09, "hypophosphataemia": 2.06, "hypopyon": 6.48, "hypovolaemia": 2.66, "hypoxia": 2.19, "ileus paralytic": 2.22, "immunosuppression": 3.69, "infection": 3.68, "intentional product use issue": 2.39, "intestinal perforation": 2.07, "klebsiella infection": 10.36, "laboratory test abnormal": 2.37, "large intestine perforation": 4.05, "leukocytosis": 2.8, "leukopenia": 2.32, "light chain analysis increased": 63.06, "live birth": 5.86, "low birth weight baby": 8.45, "lower respiratory tract infection": 2.44, "lung abscess": 6.38, "lung infiltration": 2.75, "lung opacity": 2.57, "lymphocyte count decreased": 2.69, "lymphopenia": 8.15, "maligt neoplasm progression": 2.15, "maternal exposure during pregcy": 2.04, "meningitis": 2.1, "meningitis cryptococcal": 10.53, "meningitis tuberculous": 24.88, "mucormycosis": 16.22, "mucosal inflammation": 3.42, "multiple organ dysfunction syndrome": 4.95, "myelodysplastic syndrome": 7.37, "myelosuppression": 4.79, "myopathy": 2.65, "necrosis": 2.74, "neonatal respiratory distress syndrome": 6.92, "neoplasm": 2.11, "neoplasm skin": 10.73, "neuropathy peripheral": 8.0, "neurotoxicity": 2.59, "neutropenia": 4.47, "neutropenic colitis": 11.16, "neutropenic sepsis": 16.13, "neutrophil count decreased": 3.67, "neutrophilia": 4.19, "normal newborn": 2.84, "off label use": 3.03, "oral candidiasis": 2.07, "osteomyelitis": 2.29, "osteonecrosis of jaw": 5.64, "pancytopenia": 5.45, "paraplegia": 3.08, "pathological fracture": 5.78, "peripheral sensory neuropathy": 6.42, "plasma cell leukaemia": 36.98, "plasma cell myeloma": 43.01, "plasma cell myeloma recurrent": 84.25, "plasma cell myeloma refractory": 230.79, "plasmacytoma": 31.28, "platelet count decreased": 3.76, "pneumocystis jirovecii pneumonia": 10.63, "pneumonia": 3.53, "pneumonia bacterial": 3.58, "pneumonia cytomegaloviral": 6.41, "pneumonia fungal": 8.07, "pneumothorax": 2.07, "polyneuropathy": 4.4, "posterior reversible encephalopathy syndrome": 6.59, "premature baby": 10.26, "premature delivery": 7.39, "premature labour": 2.69, "product use in unapproved indication": 2.17, "progressive multifocal leukoencephalopathy": 8.7, "pseudomonas infection": 5.92, "pulmonary haemorrhage": 3.27, "respiratory failure": 3.25, "respiratory tract infection": 2.67, "sepsis": 4.96, "septic shock": 6.71, "skin mass": 2.17, "spinal compression fracture": 3.31, "staphylococcal bacteraemia": 6.71, "staphylococcal infection": 2.25, "steroid diabetes": 14.73, "stridor": 2.7, "strongyloidiasis": 67.79, "systemic candida": 8.2, "therapeutic response decreased": 2.98, "therapy non-responder": 5.5, "therapy partial responder": 10.13, "thrombocytopenia": 4.17, "thrombotic microangiopathy": 2.94, "toxic epidermal necrolysis": 3.16, "tumour lysis syndrome": 14.25, "type i hypersensitivity": 2.65, "upper respiratory tract infection": 2.79, "vulvovaginal mycotic infection": 2.05, "white blood cell count decreased": 2.37}